Human Genes and Microbiota in Early Life

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorGuangzhou Women and Children's Medical Center

About this trial

The long-term goal of the Human Genes and Microbiota in Early Life (HuGME) is to explore the short- and long-term effects of maternal microbiota during pregnancy and the microbiota colonization of their offspring early in life and their interaction with the host on maternal-offspring health consequences in later life in the born in Guangzhou cohort study in China. Identification of the effect of microbiota in early life, as well as environmental factors and microbe-host interaction, will lead to a better understanding of disease pathogenesis and provide a foundation for targeted mechanistic investigation into the consequences of microbial-host crosstalk for long-term health. It also can result in new strategies to predict and prevent diseases in later life.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial population

Pregnant women attending their first routine antenatal examinations (usually around week 16) and their partners and offsrping

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • No intervention

    Other intervention

    No intervention

Treatment groups

20,000 Participants
are divided into 1 treatment group
Group A: No treatment1 intervention

Trial outcomes

Primary outcomes

1

Numbers of participants with Childhood diseases. Including:

Obesity,asthma,allergic diseases,Delayed neural development,type 1 diabetes,maturity-onset diabetes of the young(MODY), hypertension

Time frame
42 days, 6 months, 1, 3, 6, 8-9, 14, and18 years of age
2

Numbers of participants with maternal diseases. Including:

Obesity,asthma,allergic diseases,type 1 diabetes,type 2 diabetes, hypertension , cardiovascular diseases,and obstetric complications,including gestational diabetes,pregnancy induced hypertension, ect.

Time frame
during pregnancy, 42 days, 6 months, 1, 3, 6, 8-9, 14, and18 years after delivery

Secondary outcomes

1

Neurodevelopment during early childhood

Including adaptive, gross motor, fine motor,language,and social function; assessed using Gesell Developmental Schedules

Time frame
at age of 3 years
2

Neurodevelopment during early childhood

Including adaptive, gross motor, fine motor,language,and social function; assessed using Ages and Stages Questionnaire

Time frame
at age of 3 years
3

Neurodevelopment during preschool age

Including solving skills, pattern perception, and logical thinking;assessed using Raven's Standard Progressive Matrices

Time frame
at age of 6 years
4

Neurodevelopment during preschool age

Including solving skills, pattern perception, and logical thinking;assessed using Peabody Picture Vocabulary Test

Time frame
at age of 6 years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.